Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-19

Clinical Trial Update: PTSD Prevention Using Oral Hydrocortisone [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated whether oral hydrocortisone given after trauma can prevent post-traumatic stress disorder and acute stress disorder. The study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Rachel Yehuda | Conditions: PTSD, Acute Stress Disorder | Phase 2 | Status: COMPLETED